8 Root Cause Investigation (RCI) Workshops.
3 cities.
110 associates trained in Fishbone analysis, 5 Why methodology, and more.
Because stronger investigations lead to stronger CAPAs, fewer recurrences, and consistent quality.
#RootCauseAnalysis#OperationalExcellence
What if your commute could improve your health?
An IISc study on Bengaluru’s Namma Metro shows better activity, wellbeing, and lower exposure to pollution.
83% are ready to switch.
biocon.com/iisc-study-finds-…
Could this reshape how cities design mobility?
#NammaMetro#Bengaluru
What makes an oral dosage form work in real life, not just in the lab?
At CPHI NA 2026, the conversations focused on reducing variability and designing for patient experience.
Watch the full session: youtu.be/4dgDifO-jvo#PatientCentricity#CRDMO#Pharma
Recognized by SAP for digital procurement transformation.
At Syngene, SAP Ariba connects 3,500 suppliers into one unified ecosystem.
Better visibility. Stronger compliance. Smarter decisions at scale.
#Syngene#DigitalTransformation#Procurement#SAP#SupplyChain
Funding cycles and approvals can quietly slow progress.
Starting Cell Line Development early helps keep your program moving while certainty catches up.
Learn how the mAb Accelerator Program supports forward momentum: syngeneintl.com/mab-accelera…#Biologics#mAb#CDMO#Biotech
Nature inspires the solutions our future needs.
This #WorldEnvironmentDay, Syngene is committed to a 54.6% reduction in Scope 1 & 2 emissions by 2033. We've already achieved 83% of that target, driven by renewable energy investments.
#Nature#ClimateAction#Sustainability
Think a high Margin of Safety is enough?
It is only one part of a much bigger safety story.
The right Point of Departure, solid data, and real-use context all need to align for your rationale to hold under scrutiny.
Read more: syngeneintl.com/preclinical-…#Cosmetics#MarginOfSafety
What is the biggest risk to taking your molecule to market?
Day 1 at CPHI NA brought the energy and the conversations keep improving.
If you are there, stop by Booth #1300 to talk challenges and smarter ways to keep programs moving.
#CPHINorthAmerica#Syngene
Drug discovery isn’t a straight line and students deserve to know that early.
At Osmania University, Syngene shared how science, data, and collaboration come together in the real world.
#Syngene#DrugDiscovery
AI in drug discovery isn’t about replacing scientists. It’s about helping them decide faster, with better data.
Here’s how AI is being embedded into real scientific workflows at Syngene.
Read more: syngeneintl.com/resources/bl…#Syngene#AI
Syngene receives the Golden Peacock National Quality Award 2026, adjudged by a jury chaired by Hon’ble Justice Uday U. Lalit, Former Chief Justice of India.
Quality delivers best when it is built in, not checked later.
#Syngene#Quality
Syngene’s digital backbone is now live.
Syngene’s Enterprise IIoT Control Center is now live, creating a real-time command layer across safety, utilities, and engineering assets to support resilient, compliant operations at scale.
#SmartManufacturing
Thrilled to welcome Prateek as Head of Biopharmaceutical Development at Syngene.
With experience across OneSource Specialty Pharma, Intas, Pfizer, and Genentech, he brings strong depth in development, process sciences, and R&D leadership.
#Biologics#Syngene
Consistency and care are what make safety cultures strong.
Our Half‑Yearly Health Check‑Up at Biocon Park brought teams together around preventive care and well‑being.
Because feeling looked after helps people do their best work.
#EmployeeWellbeing#SafetyCulture#Syngene
Great energy. Real conversations.
From risk to roadmap, CDMO Live reinforced what matters most to partners.
Shared ownership, early alignment, fewer surprises.
#CDMOLive#CDMO#BiopharmaPartnerships#DrugDevelopment
Excellence that delivers for our clients.
Stories of Excellence 2026 celebrated Quality, Analytical Development, Engineering & Maintenance, MSEZ, and Translational & Clinical Research for turning ideas into real impact.
#Syngene#Excellence
The energy at CDMO Live is contagious.
Our team is deep in conversations with people shaping what partnership really means in drug development.
If you are here, stop by booth G22.
#CDMOLive#BiopharmaCommunity#CDMO#Syngene
Scale‑up can stall even the strongest oligonucleotide pipelines.
Building manufacturability in early helps maintain momentum.
At Syngene, development and manufacturing are tightly linked.
Talk to our experts: go.pardot.com/l/595011/2025-…#Oligonucleotides#Oligos#DrugDevelopment
Speed increases as molecules mature, but robustness cannot slip.
An integrated SMCDMO approach helps cut rework and keep control as complexity grows.
Because progress should not feel like firefighting.
📍Meet Syngene at Booth #1300.
#SMCDMO#CPHINorthAmerica